|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| IBC's Well Characterized Biologicals | ||||||||||||||||
| May 29, 2002 | ||||||||||||||||
|
IBC Life Sciences, Bethesda Marriott Hotel, Bethesda, MD September 30 - October 3, 2002 IBC’s Well Characterized Biologicals Conference continues to serve as a leading industry forum for updates on new technologies in analytical characterization and the evolution of regulations in response to these advances. |
||||||||||||||||
| Organized by: | IBC Life Sciences | |||||||||||||||
| Invited Speakers: | Scientific Advisory Committee Gary Bird, Ph.D., Quality Technical Advisor, Quality Control Development, Eli Lilly & Co. Mark Brunswick, Ph.D., Senior Regulatory Scientist, Science Applications International Corporation Peter H. Calcott, Ph.D., Corporate VP, Quality and CQO, Chiron Corporation Michael G. Mulkerrin, Ph.D., Director, Analytical Biochemistry, Abgenix, Inc. Mark A. Schenerman, Ph.D., Senior Director, Analytical Biochemistry, MedImmune, Inc. Ashvin Patel, Head of Molecular Analysis, GlaxoSmithKline, United Kingdom |
|||||||||||||||
| Deadline for Abstracts: | - | |||||||||||||||
| Registration: | Five Easy Ways to Register! Phone (508) 616-5550 Fax (508) 616-5522 E-mail reg@ibcusa.com IBC USA Conferences, Inc. One Research Drive Suite 400A Westborough, MA 01581-5195 On-line www.LifeSciencesInfo.com/wcb |
|||||||||||||||
| E-mail: | reg@ibcusa.com | |||||||||||||||
| Posted by: | James G. Prudhomme | |||||||||||||||
| Host: | 208.252.12.3 | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||